1. Home
  2. NVCR vs DV Comparison

NVCR vs DV Comparison

Compare NVCR & DV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVCR
  • DV
  • Stock Information
  • Founded
  • NVCR 2000
  • DV 2008
  • Country
  • NVCR Switzerland
  • DV United States
  • Employees
  • NVCR N/A
  • DV N/A
  • Industry
  • NVCR Medical/Dental Instruments
  • DV Computer Software: Prepackaged Software
  • Sector
  • NVCR Health Care
  • DV Technology
  • Exchange
  • NVCR Nasdaq
  • DV Nasdaq
  • Market Cap
  • NVCR 1.9B
  • DV 2.2B
  • IPO Year
  • NVCR 2015
  • DV 2021
  • Fundamental
  • Price
  • NVCR $15.58
  • DV $12.48
  • Analyst Decision
  • NVCR Buy
  • DV Buy
  • Analyst Count
  • NVCR 6
  • DV 19
  • Target Price
  • NVCR $34.17
  • DV $20.42
  • AVG Volume (30 Days)
  • NVCR 736.7K
  • DV 2.6M
  • Earning Date
  • NVCR 04-24-2025
  • DV 05-08-2025
  • Dividend Yield
  • NVCR N/A
  • DV N/A
  • EPS Growth
  • NVCR N/A
  • DV N/A
  • EPS
  • NVCR N/A
  • DV 0.32
  • Revenue
  • NVCR $605,220,000.00
  • DV $656,849,000.00
  • Revenue This Year
  • NVCR $3.14
  • DV $13.24
  • Revenue Next Year
  • NVCR $10.63
  • DV $12.97
  • P/E Ratio
  • NVCR N/A
  • DV $39.00
  • Revenue Growth
  • NVCR 18.82
  • DV 14.72
  • 52 Week Low
  • NVCR $11.70
  • DV $11.52
  • 52 Week High
  • NVCR $34.13
  • DV $31.15
  • Technical
  • Relative Strength Index (RSI)
  • NVCR 34.24
  • DV 37.80
  • Support Level
  • NVCR $15.49
  • DV $11.86
  • Resistance Level
  • NVCR $17.06
  • DV $12.97
  • Average True Range (ATR)
  • NVCR 1.06
  • DV 0.73
  • MACD
  • NVCR -0.01
  • DV 0.14
  • Stochastic Oscillator
  • NVCR 20.42
  • DV 46.72

About NVCR NovoCure Limited

NovoCure Ltd serves in the healthcare sector of the United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.

About DV DoubleVerify Holdings Inc.

DoubleVerify Holdings Inc is a digital media measurement and analytics software platform. Its solutions provide advertisers with unbiased data analytics that enable them to increase the effectiveness, quality, and return on their digital advertising investments. Its DV Authentic Ad, a proprietary metric of digital media quality, measures whether a digital ad was delivered in a brand-suitable environment, fully viewable, by a real person, and in the intended geography. The company's software interface, DV Pinnacle, delivers these metrics to customers in real time, allowing them to access critical performance data on their digital transactions. Geographically, the company operates in the United States and also has a presence in Germany, Singapore, France, Canada, Japan, and other countries.

Share on Social Networks: